Thanks to precision medicine, medical care is getting personal — highly personal. Described as the future of medicine, precision medicine technologies enable doctors and researchers to analyze what a person’s genes say about them and how that relates to a specific diagnosis. The intention is that precision medicine can provide more accurate care, especially when it comes to cancers, COVID-19, and other rare disorders.
One leader in the field of precision medicine is David C. Fajgenbaum, M.D., MBA, MSc. Dr. Fajgenbaum is an associate professor of medicine in translational medicine and human genetics at the University of Pennsylvania. He is also the founding director of the Center for Cytokine Storm Treatment and Laboratory (CSTL), which aims to identify and treat patients with Castleman disease, COVID-19, and other cytokine storm disorders. CSTL works to uncover “novel diagnostic biomarkers and therapeutics, identify optimal treatment approaches, and to provide world-class patient care,” as noted on med.upenn.edu/CSTL. more